Opko Health reported $217.74M in Loan Capital for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Agios Pharmaceuticals AGIO:US USD 1.06M 0
ALKERMES ALKS:US USD 290.9M 633K
Alnylam Pharmaceuticals ALNY:US USD 1.02B 338.25M
Arrowhead Research ARWR:US USD 0 0
Biomarin Pharmaceutical BMRN:US USD 1.08B 986K
Bristol Myers Squibb BMY:US USD 36.97B 141M
Esperion Therapeutics ESPR:US USD 259.49M 407K
Exact Sciences EXAS:US USD 2.24B 2.38M
Halozyme Therapeutics HALO:US USD 1.49B 344.03M
Insmed INSM:US USD 807.48M 366K
Intercept Pharmaceuticals ICPT:US USD 222.86M 491M
IONIS PHARMACEUT IONS:US USD 1.25B 1.1M
Ironwood Pharmaceuticals IRWD:US USD 395.85M 399K
Laboratory Of America LH:US USD 5.42B 22.1M
Moderna Inc MRNA:US USD 922M 281M
Ptc Therapeutics PTCT:US USD 981.61M 165K
Quest Diagnostics DGX:US USD 3.98B 3M
Sarepta Therapeutics SRPT:US USD 1.54B 441.9M
Teva Pharmaceutical Industries TEVA:US USD 18.5B 1.87B
United Therapeutics UTHR:US USD 800M 0